Although current animal studies indicate that roxadustat does not promote the occurrence, progression, or metastasis of VEGF-sensitive NeuYD mouse tumors [57,58], there is limited data on its effect on human tumor incidence. The gene discussed is VEGFA; the disease is neoplasm.